NPTX2, a synaptic protein, which has previously been shown to be reduced in CSF from patients with FTD and is potentially one of the first protein biomarkers to become abnormal in genetic FTD [3, 23, 24]. Here, NPTX2 is linked to frontotemporal dementia.